BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36569943)

  • 1. Different local, innate and adaptive immune responses are induced by two commercial
    Beuckelaere L; Haspeslagh M; Biebaut E; Boyen F; Haesebrouck F; Krejci R; Meyer E; Gleerup D; De Spiegelaere W; Devriendt B; Maes D
    Front Immunol; 2022; 13():1015525. PubMed ID: 36569943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs.
    Arsenakis I; Panzavolta L; Michiels A; Del Pozo Sacristán R; Boyen F; Haesebrouck F; Maes D
    BMC Vet Res; 2016 Mar; 12():63. PubMed ID: 27025924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
    Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
    BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of Mycoplasma hyopneumoniae-specific immunity in vaccinated pigs.
    Biebaut E; Beuckelaere L; Boyen F; Haesebrouck F; Gomez-Duran CO; Devriendt B; Maes D
    Vet Res; 2023 Mar; 54(1):16. PubMed ID: 36859402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
    Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
    Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems Immunology Characterization of Novel Vaccine Formulations for
    Matthijs AMF; Auray G; Jakob V; García-Nicolás O; Braun RO; Keller I; Bruggman R; Devriendt B; Boyen F; Guzman CA; Michiels A; Haesebrouck F; Collin N; Barnier-Quer C; Maes D; Summerfield A
    Front Immunol; 2019; 10():1087. PubMed ID: 31178860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
    Mechler-Dreibi ML; Almeida HMS; Sonalio K; Martines MAC; Petri FAM; Zambotti BB; Ferreira MM; Storino GY; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
    Sci Rep; 2021 Nov; 11(1):22377. PubMed ID: 34789792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.
    Thacker EL; Thacker BJ; Kuhn M; Hawkins PA; Waters WR
    Am J Vet Res; 2000 Nov; 61(11):1384-9. PubMed ID: 11108184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of Mycoplasma hyopneumoniae-specific cell mediated immunity to neonatal piglets.
    Biebaut E; Beuckelaere L; Boyen F; Haesebrouck F; Gomez-Duran CO; Devriendt B; Maes D
    Vet Res; 2021 Jun; 52(1):96. PubMed ID: 34193259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
    Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
    BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
    Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
    Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
    Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae.
    Matthijs AMF; Auray G; Boyen F; Schoos A; Michiels A; García-Nicolás O; Barut GT; Barnier-Quer C; Jakob V; Collin N; Devriendt B; Summerfield A; Haesebrouck F; Maes D
    Vet Res; 2019 Nov; 50(1):91. PubMed ID: 31703726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
    Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G
    Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs.
    Li Y; Li P; Wang X; Yu Q; Yang Q
    Vaccine; 2012 Mar; 30(12):2153-8. PubMed ID: 22266290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination reduces macrophage infiltration in bronchus-associated lymphoid tissue in pigs infected with a highly virulent Mycoplasma hyopneumoniae strain.
    Vranckx K; Maes D; Marchioro SB; Villarreal I; Chiers K; Pasmans F; Haesebrouck F
    BMC Vet Res; 2012 Mar; 8():24. PubMed ID: 22409839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.
    Maes D; Boyen F; Devriendt B; Kuhnert P; Summerfield A; Haesebrouck F
    Vet Res; 2021 May; 52(1):67. PubMed ID: 33964969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination inhibits TLR2 transcription via suppression of GR nuclear translocation and binding to TLR2 promoter in porcine lung infected with Mycoplasma hyopneumoniae.
    Sun Z; Liu M; Zou H; Li X; Shao G; Zhao R
    Vet Microbiol; 2013 Dec; 167(3-4):425-33. PubMed ID: 24035265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cell-mediated immunity induced by three commercial single-dose Mycoplasma hyopneumoniae bacterins in pigs.
    Seo HW; Han K; Oh Y; Park C; Choo EJ; Kim SH; Lee BH; Chae C
    J Vet Med Sci; 2013 Feb; 75(2):245-7. PubMed ID: 23059842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.